Sort   by:  
 Page size 
UnknownROR1 and ROR2 expression in pancreatic cancer.
Not available
S-EPMC8582180 | biostudies-literature
UnknownMapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification.
Not available
S-EPMC12548992 | biostudies-literature
UnknownCAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.
Not available
S-EPMC6691013 | biostudies-literature
UnknownA first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.
Not available
S-EPMC10518255 | biostudies-literature
UnknownThe deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.
Not available
S-EPMC3376394 | biostudies-literature
UnknownHNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer.
Not available
S-EPMC9511995 | biostudies-literature
UnknownTargeting DNA Damage Response and Replication Stress in Pancreatic Cancer.
Not available
S-EPMC8167930 | biostudies-literature
UnknownResults of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922 | biostudies-literature
UnknownThe National Lung Screening Trial: overview and study design.
Not available
S-EPMC3009383 | biostudies-literature
UnknownWhole genomes redefine the mutational landscape of pancreatic cancer.
Not available
S-EPMC4523082 | biostudies-literature
Sort   by:  
 Page size